Urine Aquaporin-2 Level is a Novel Marker for the Better Prognosis After Long-Term Tolvaptan Treatment in Patients With Advanced Heart Failure

被引：0
|
作者：
Imamura, Teruhiko
Kinugawa, Koichiro
Fujino, Takeo
Inaba, Toshiro
Maki, Hisataka
Hatano, Maasaru
Yao, Atsushi
Komuro, Issei
机构：
来源：
CIRCULATION | 2014年 / 130卷
关键词：
Diuretics; Kidney; Vasopressins;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
9411
引用
收藏
页数：4
相关论文
共 50 条
  • [31] Safety and Efficacy of Long-Term Use of Tolvaptan in Patients With Heart Failure and Chronic Kidney Disease
    Uemura, Yusuke
    Shibata, Rei
    Takemoto, Kenji
    Uchikawa, Tomohiro
    Koyasu, Masayoshi
    Ishikawa, Shinji
    Imai, Ryo
    Ozaki, Yuta
    Watanabe, Takashi
    Teraoka, Tsubasa
    Watarai, Masato
    Murohara, Toyoaki
    CIRCULATION JOURNAL, 2017, 81 (11) : 1736 - +
  • [32] D-dimer is a strong marker of in-hospital and long-term prognosis in patients with decompensated heart failure
    Bittencourt, M. I.
    Rocha, R. Mourilhe
    Esporcatte, R.
    Rey, H. C. V.
    Oliveira, F. T.
    Salgado, C. G.
    Ferreira, F.
    Rangel, F. O. D.
    EUROPEAN HEART JOURNAL, 2005, 26 : 71 - 71
  • [33] Tolvaptan Improves the Long-Term Prognosis in Patients With Congestive Heart Failure With Preserved Ejection Fraction as Well as in Those With Reduced Ejection Fraction
    Imamura, Teruhiko
    Kinugawa, Koichiro
    INTERNATIONAL HEART JOURNAL, 2016, 57 (05) : 600 - 606
  • [34] Impact of Worsening Heart Failure on Long-Term Prognosis in Patients With Heart Failure With Reduced Ejection Fraction
    Chimed, Surenjav
    Stassen, Jan
    Galloo, Xavier
    Meucci, Maria Chiara
    van der Bijl, Pieter
    Knuuti, Juhani
    Delgado, Victoria
    Marsan, Nina Ajmone
    Bax, Jeroen J.
    AMERICAN JOURNAL OF CARDIOLOGY, 2022, 184 : 63 - 71
  • [35] Influence of Gender on Long-term Prognosis of Patients With Chronic Heart Failure Seen in Heart Failure Clinics
    Jimenez-Navarro, Manuel F.
    Ramirez-Marrero, Miguel A.
    Anguita-Sanchez, Manuel
    Carlos Castillo, Juan
    CLINICAL CARDIOLOGY, 2010, 33 (03) : E13 - E18
  • [36] Long-Term Compliance With Nonpharmacologic Treatment of Patients With Heart Failure
    Nieuwenhuis, Maurice M. W.
    Jaarsma, Tiny
    van Veldhuisen, Dirk J.
    Postmus, Douwe
    van der Wal, Martje H. L.
    AMERICAN JOURNAL OF CARDIOLOGY, 2012, 110 (03): : 392 - 397
  • [37] Treatment of Heart Failure in Long-term Dialysis Patients: A Reappraisal
    Wang, Angela Yee-Moon
    Sanderson, John E.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2011, 57 (05) : 760 - 772
  • [38] Clinical features and long-term prognosis of patients with congestive heart failure taking tolvaptan: a comparison of patients with preserved and reduced left ventricular ejection fraction
    Toshiki Seki
    Yoshiaki Kubota
    Junya Matsuda
    Yukichi Tokita
    Yu-ki Iwasaki
    Wataru Shimizu
    Heart and Vessels, 2022, 37 : 574 - 582
  • [39] Clinical features and long-term prognosis of patients with congestive heart failure taking tolvaptan: a comparison of patients with preserved and reduced left ventricular ejection fraction
    Seki, Toshiki
    Kubota, Yoshiaki
    Matsuda, Junya
    Tokita, Yukichi
    Iwasaki, Yu-ki
    Shimizu, Wataru
    HEART AND VESSELS, 2022, 37 (04) : 574 - 582
  • [40] Characteristics and long-term prognosis of patients with heart failure and mid-range
    Abdulla, J.
    Lauritsen, J.
    Gustafsson, F.
    EUROPEAN JOURNAL OF HEART FAILURE, 2018, 20 : 46 - 46
12345